期刊
NEUROSCIENCE LETTERS
卷 442, 期 2, 页码 143-147出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2008.07.007
关键词
erythropoietin; A beta; PC12 cells; apoptosis; oxidative stress
Erythropoietin (EPO), a haematopoietic growth factor has been reported to display neuroprotective properties in different animal models. In the present study, we investigated the neuroprotective effects of EPO on A beta(25-35)-induced neuronal toxicity and its potential mechanisms in PC12 cells. A beta(25-35) significantly reduced cell viability and increased the number of apoptotic-like cells. In addition, increased ROS production and decreased mitochondrial membrane potential were also found after A beta(25-35) exposure. All of these phenotypes induced by A beta(25-35) were markedly reversed by EPO. Pretreatment with EPO prior to A beta(25-35) exposure significantly elevated cell viability, reduced A beta(25-35)-induced apoptosis, decreased ROS production, and stabilized mitochondrial membrane potential. Furthermore, EPO also attenuated the downstream cascade following ROS, including Bcl-2/Bax, and caspase-3 activation. Our results suggest that EPO holds potential for neuroprotection and therefore, may be promising for the treatment of Alzheimer's disease. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据